Cooper Companies Stock: Analyst Estimates & Ratings

Company Overview - The Cooper Companies, Inc. (COO) has a market cap of $14.4 billion and operates globally in the medical device sector, focusing on contact lenses through CooperVision and women's and family health care products via CooperSurgical [1] Stock Performance - COO shares have underperformed the broader market over the past 52 weeks, declining 27.4% while the S&P 500 Index gained 12.3% [2] - Year-to-date, COO shares have decreased by 21.5%, compared to a 12.5% return for the S&P 500 [2] Financial Performance - In Q3 2025, COO reported adjusted EPS of $1.10, which was stronger than expected, but shares fell 12.9% the following day due to missed revenue estimates of $1.06 billion [4] - The company revised its full-year revenue guidance down to $4.07 billion - $4.10 billion, citing a significant drop in contact lens demand in Asia, particularly China, and a slowdown in the U.S. market [4] Analyst Expectations - For the fiscal year ending in October 2025, analysts project a 10.8% year-over-year growth in adjusted EPS to $4.09 [5] - The consensus rating among 17 analysts is a "Moderate Buy," with nine "Strong Buy" ratings, one "Moderate Buy," six "Holds," and one "Strong Sell" [5] Analyst Ratings and Price Targets - The current analyst configuration is slightly less bullish than three months ago, with 10 "Strong Buy" ratings previously [6] - Wells Fargo analyst downgraded COO to "Hold" with a price target of $72, while the mean price target of $81.88 suggests a 13.4% premium to the current price [6] - The highest price target of $96 indicates a potential upside of nearly 33% [6]